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Abstract 
Word count: 270 
Background Clinical practice guidelines (CPGs) are typically written for health care 
professionals but are meant to assist patients with health care decisions. A number of guideline 
producers have started to develop patient versions of CPGs to reach this audience. 
Objective To describe the content and purpose of patient versions of CPGs and compare to 
patient and public views of CPGs. 
Design A descriptive qualitative study with a directed content analysis of a sample of patient 
versions of CPGs published and freely available in English from 2012-2014. 
Results We included 34 patient versions of CPGs from 17 guideline producers. Over half of the 
patient versions were in dedicated patient sections of national/professional agency websites. 
There was essentially no information about how to manage care in the health care system. The 
most common purpose was to equip people with information about disease, tests or treatments, 
and recommendations, but few provided quantitative data about benefits and harms of 
treatments. Information about beliefs, values and preferences, accessibility, costs or feasibility of 
the interventions was rarely addressed. Very few provided personal stories or scenarios to 
personalise the information. Three versions described the strength of the recommendation or the 
level of evidence. 
Limitations Our search for key institutions that produce patient versions of guidelines was 
comprehensive, but we only included English and freely available versions. Future work will 
include other languages. 
Conclusions This review describes the current landscape of patient versions of CPGs and 
suggests that these versions may not address the needs of their targeted audience. Research is 
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needed about how to personalise information, provide information about factors contributing to 
the recommendations, and provide access. 
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Introduction 
Clinical practice guidelines (CPGs) provide health care recommendations and are meant to help 
both clinicians and patients make decisions about their health care [1]. However, CPGs have 
traditionally been developed to communicate information to clinicians, but CPGs could provide 
very useful information to  the general population, i.e. patients (including carers) and other 
members of the public. There is a wealth of information in CPGs, such as information about the 
effects of tests or treatments, the quality of that evidence, and clear recommendations which 
factor in patient values and preferences, resources, feasibility and other issues such as equity [2]. 
To tailor this information to patients, guideline producers could consider the expanding evidence 
base about how to produce patient information and for what purpose. Dixon-Woods has 
identified a variety of purposes for patient information to educate and empower [3]. Information 
to educate people is traditionally about conditions and treatments in order to save time during 
consultations, and to enhance compliance with recommendations. In contrast, materials for 
patient empowerment build upon patient education, and also include information to help people 
consider their own experiences, preferences and resources to inform decisions [3]. While 
building on the research for communicating research to patients is helpful, our recent systematic 
review of the literature about patient and public attitudes to CPGs found that there may be unique 
factors to consider when communicating guidelines [4]. Our review found that people may not 
always perceive guidelines positively. Some people thought CPGs could limit their decision 
making by providing rules about their treatment options, may not be trustworthy or credible, and 
may not be applicable to their own situations. Nevertheless, others thought that patient versions 
of CPGs could provide information about how to manage their own care, could be used as a tool 
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when speaking with their health care providers, and could potentially help them make decisions 
if the right information was provided.  
Although attention has recently been directed towards the development of patient decision aids 
to help people participate in health care decisions that are based on guideline recommendations 
[5,6],a number of guideline producers have already been developing patient versions of CPGs: 
SIGN (Scottish Intercollegiate Guidelines Network) has produced over 30 patient versions based 
on their CPGs and NICE (National Institute for Health and Care Excellence) has over 150 CPG 
patient versions available. A survey conducted by Kryworuchko and colleagues from 1994 to 
2005 found that 42% of guideline producers are targeting patients with versions different from 
the CPGs [7], and a recent review of international programmes to involve patients and the public 
revealed that 18/71 of the organisations involve patients in the development of products for 
patients and the public based on CPGs [8]. Given this work, guideline producers now have the 
opportunity to learn from what is currently being developed and build on that knowledge base 
while considering the unique factors which may play a role in the use of guidelines by patients 
and the public. The aim of this descriptive qualitative study is to describe patient versions of 
CPGs available using a directed content analysis. We include a description of the format of 
patient versions and the content, with a particular focus on the stated and latent purposes of the 
patient versions. Based on the analysis, we describe the landscape of patient versions, compare it 
to the views of patients and the public, and make suggestions for future research. 
 
Methods 
Study design 
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We conducted a qualitative descriptive study with a directed content analysis of a sample of 
patient versions available from key institutions producing CPGs [9]. A directed content analysis 
is a research method used to systematically classify and analyse the text from documents. While 
content analysis can be quantitative (e.g. counting the frequency in which certain words are 
used), the qualitative analysis used in this study allows for an interpretation of the text to identify 
explicit and inferred meanings [9]. Below are the detailed methods we used to describe the 
characteristics of the patient versions, summarise and quantify the type of information provided, 
identify the purpose of the patient versions, and briefly describe how recommendations and 
evidence are communicated.  
 
Sample: Identification of patient versions  
Because our overarching aim is to learn from guideline producers with experience currently 
producing patient versions, we conducted a search to identify patient versions of CPGs published 
between 2012 and April 2014 by key institutions producing guidelines or recommendations. We 
defined a key institution as a national, public or professional organisation with a mandate to 
produce guidelines and which had produced at least six clinical guidelines since January 2012. 
To develop the list of key institutions, we reviewed the members’ list of a large guideline 
network: the GRADE Working Group (an informal international group of people interested in 
methods for guideline development) including members of GRADE’s DECIDE project (a project 
for Developing and Evaluating Communication Strategies to Support Informed Decisions and 
Practice Based on Evidence). We visited the websites of those institutions to search for patient 
versions. We also searched databases which include guidelines: the International Guideline 
Library produced by the Guidelines International Network (GIN), the CMA Infobase (a database 
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of guidelines from the Canadian Medical Association); the National Health and Medical 
Research Council Clinical Practice Guidelines Portal from Australia; and the NICE Evidence 
Search in the United Kingdom. We searched these databases for guidelines produced between 
2012 and 2014 by restricting to those dates. We organised the search from each database by 
organisation, and then deleted institutions that produced less than six guidelines. We visited the 
websites of those institutions to determine if they had produced patient versions (see inclusion 
criteria below for a definition of patient version). We also searched the National Guideline 
Clearing House (NGC) using the advanced search and restricted to 2012-2014 and used the filter 
for ‘only include guidelines that have/incorporate: patient resources’ to find institutions 
producing patient versions. One investigator screened through the institutions from the search 
using the a priori inclusion criteria. We compiled a list of all included institutions and a list of all 
patient versions according to the criteria below. 
 
Inclusion criteria 
From each institution, we randomly sampled two patient versions produced between January 
2012 and April 2014 by using the random function in Excel. The selection of two samples was 
based on a preliminary analysis of four patient versions from two institutions which when 
analysed had provided very similar results. We included patient versions which met all of the 
following criteria:1. defined as a patient version/information by the organisation; 2. based on a 
CPG or Recommendations for clinicians; 3. produced by organisations with experience 
producing patient versions - indicated by more than four topic specific patient versions produced 
between 2012 and 2014; 4. available publicly; and, 5. published in English.  
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Data extraction  
We took a directed (deductive) approach to content analysis as described by Hsieh and Shannon 
[10]. We developed a coding form and data abstraction sheet for manifest and latent content 
based on categories informed by the literature about patient education materials and research into 
disseminating guidelines and recommendations to practitioners [2,3,4,11]. Key components of 
the patient versions were extracted: format of the patient versions (e.g. length, booklet), types of 
information provided (background, tests or treatments, evidence, recommendations, and 
additional information), the purpose of the patient versions, and communication of 
recommendations and evidence (see Supporting Information for the key components extracted 
and themes). We used the work from Dixon-Woods [3] to develop a list of the purposes of 
patient versions; we identified recommendations using the criteria outlined by Hussain [11]; 
identified important factors unique to guideline recommendations, such as patient values and 
preferences using the GRADE approach [2]; and used the themes found in the systematic review 
of patient and public attitudes towards CPGs (personalisation, credibility, purpose and format 
issues) [4]. Two investigators piloted the form using four patient versions and discussed results 
to check intercoder reliability and consistency, and then revised the form accordingly. They 
independently extracted the data and compared. When new categories arose during data 
extraction, the investigators discussed and agreed and re-extracted data from the documents.  
 
Data analysis 
Data were managed using an electronic database. The two investigators compared the 
quantitative data abstracted for discrepancies and resolved disagreements. We calculated 
frequency data as proportions of guidelines that included a component, and calculated a median 
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and interquartile range (IQR) for continuous data (e.g. percent of document which was 
background information). For content related to the purpose of the documents, we created 
separate tables and compared our assessment of the presence or absence of a purpose. 
Disagreements were discussed between the two investigators until consensus was reached. We 
provided a qualitative description of the purpose of the patient versions, and illustrated the 
purpose through examples.  
 
Funding 
Financial support for this study was provided by the Canadian Institutes of Health Research 
Fellowship in Knowledge Translation and for the DECIDE project from the European Union’s 
Seventh Framework Programme under grant agreement n°258583. The funding agreement 
ensured the authors’ independence in designing the study, interpreting the data, writing, and 
publishing the report. 
 
Results 
We found 38 key institutions that met our inclusion criteria, and 21 institutions from NGC using 
the ‘patient’ limits. Of these, 42 had not produced more than four patient versions between 2012-
April 2014. We therefore included 17 organisations which had produced from 4 to 53 patient 
versions each. We sampled two patient versions from each for a total of 34 patient versions (see 
Table 1). A variety of medical topics were covered including cancer (breast, lung, prostate, 
esophageal, pancreatic and melanoma), women’s health and reproduction, gastrointestinal 
conditions, diabetes and mental health. Most patient versions (24/34) primarily focused on 
guidelines about treatment, but many also covered diagnosis, screening and/or prevention. A 
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summary of the characteristics of the patient versions is available in Table 2 and described 
below.  
 
[insert table 1] 
 
Location of patient versions 
Over half of patient versions (20/34) were found in dedicated patient sections of national and 
professional agency websites (e.g. in sections ‘For patients’ or ‘Patient Education’) or linked 
directly from the professional version of the CPG (18%). A small number (4/34) were found on 
patient dedicated websites that were affiliated with the professional organisations. Almost half of 
the patient versions (16/34) were available on websites as a printed document only and 11/34 as 
web pages which were printable. Patient versions were called a variety of names by different 
organisations and were typically referred to simply as ‘patient information’. Thirteen indicated 
that they were based on guidelines. For example, the European Society for Medical Oncology 
(ESMO) titles their versions as “Patient information based on ESMO Clinical Practice 
Guidelines,” and the American Academy of Neurology (AAN) as “Summary of Evidence-based 
Guideline for PATIENTS and their FAMILIES.”   
 
[insert table 2] 
 
Information provided in the patient versions  
The documents provided a diversity of information about the disease, anatomy, risk factors, 
symptoms and incidence. However, few documents included information about the prognosis of 
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the disease or condition. Proportionately little information consisted of background (16%, IQR 
12 to 23%) and there was essentially no information (0%, IQR 0 to 6%) about the health care 
system or how to navigate through the system. In the documents that did provide health care 
system information, it typically described the health care team involved in care. A little over 1/3 
of the documents did not include pictures, graphics or figures, but those that did often depicted 
the anatomy of the body affected by the condition or disease. 
 
Many patient versions (27/34) referred to or linked directly to the professional versions of the 
guidelines, but only half included a description of what a guideline is or how the guideline was 
developed. When guidelines were described in the patient version, it was usually at the back of 
the document. Emphasis was placed on the ‘experts’ or committees of professionals and patient 
representatives who developed the guidelines:21 documents stated that patients were involved in 
the development or review of the material. The amount of information about guidelines varied 
from a single statement to multiple paragraphs. NICE wrote: ‘NICE clinical guidelines advise the 
NHS [National Health Service] on caring for people with specific conditions or diseases and the 
treatments they should receive.’ In contrast, the United States Preventive Task Force (USPSTF) 
patient summaries describe what are guidelines, how guidelines are produced and how the 
evidence is graded. In addition to providing text within the document, SIGN also provided a link 
to a separate patient information booklet about the development of guidelines, and NICE 
includes additional information on their website. 
 
The majority (26/34) of patient versions provided links or contact information (such as telephone 
numbers) for additional information and support, and typically at the end of the document 
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(though sometimes within the document). However, the credibility of these links was sometimes 
compromised as some patient versions (4/26) also included a caveat about not being responsible 
for the content in those recommended sites. The majority of patient versions also encouraged 
people to talk to their health care provider for more information, but only five provided a section 
for ‘questions to ask your doctor.’  
 
Credibility of the information 
In addition to referring to or providing a link to the professional version or providing the 
methods for development, the most common method used to convey credibility was the use of 
the logo of the professional association and if applicable, the affiliated patient organisation 
(32/34). NICE and the Royal College of Obstetrics and Gynaecology also referenced the 
Information Standard; SIGN referenced Crystal Mark/Plain English Campaign; and the Canadian 
Paediatric Society referenced the Health on the Net Code of Conduct. 
 
[insert table 3] 
 
Purpose of the patient versions 
Twenty-one patient versions explicitly stated their purpose. All 21 aimed to educate or equip 
people with information. Eight stated an additional purpose: six stated that the goal was to 
empower people to obtain the ‘best care’; one version about HIV and pregnancy provided 
information for self-care and to stay healthy; and another about overactive bladder empowered 
patients to become more active by openly talking about the condition.  
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Our qualitative analysis identified latent purpose(s) of the patient versions and was organised 
into categories adapted from Dixon-Woods [3]. Although we did not find additional categories, 
we did refine categories. We did not find examples for some categories: persuasion for the use of 
specific interventions, to reassure or provide a second opinion, and to replace the healthcare 
consultation or counseling. Table 4 provides a list of the purposes we found and examples. 
Below we highlight these results.   
 
Similar to the stated purpose of the patient versions, the most common purpose from our 
qualitative analysis was to provide education about or equip people with information about the 
disease, the tests or treatments, and the recommendations. Even when the document was short, it 
still directed people to more information and resources. Links to additional websites, telephone 
numbers, names of other organisations were provided whether for background information, 
treatment or test information, or for support. There was, however, little information about 
benefits and harms, and again most documents advised people to speak with their health care 
providers who should provide information about the risks and benefits of treatments: ‘During 
your care and treatment, your healthcare team should give you information (including written 
information) about fertility problems and treatments to help you make informed decisions.’ 
(NICE, Assessment and treatment for people with fertility problems). When information about 
benefits and harms was provided it was generally vague and very few patient versions provided 
quantitative data about how often benefits and harms occur (Table 3). For example, the guide for 
non-small cell lung cancer from ESMO explains that treatment “…has the potential to 
significantly reduce the risk of disease recurrence and significantly improve survival.” and the 
USPSTF explains that cervical cancer screening “…may also lead to additional tests or 
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procedures that aren’t needed or that may cause harms for some women, including problems 
with future pregnancies.” Although many versions indicated that the information could be used 
to make decisions and should be discussed with the health care provider to make decisions, it 
was often not accompanied by other information to assist with decision-making. Information 
about what beliefs, values or preferences have an impact on the decision, or information about 
the accessibility, costs or feasibility of the interventions were rarely addressed. When these other 
factors were mentioned, for example in the patient version from NICE for Hyperphosphataemia 
in chronic kidney disease, the information was not specific about how these factors might play a 
role in the decision; ‘...your healthcare team will take into account which type you prefer, how 
easy they are to take, and other factors when deciding which is the most suitable for you.’ 
 
Most patient versions presented multiple options for tests and treatments, enhanced choice and 
did not appear to be about persuading people to use particular interventions. For example, both 
patient versions produced by the National Comprehensive Cancer Network not only provided a 
list and description of the treatments available for esophageal and pancreatic cancers, but also 
described and provided additional resources for information about complementary and 
alternative medicines (CAMs). Even documents that presented information about one treatment 
noted that other options should be discussed with health care providers. The patient version from 
the AAN for Vagus Nerve Stimulation (VNS) advised readers to ‘…talk with your doctor about 
therapies for treating seizures. Be sure you understand all the options available, including VNS.’ 
In contrast, the patient version describing what to expect after stillbirth, appeared to focus only 
on options for seeing the baby or taking the baby home for a period but not on other options. For 
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example, it stated: ‘If you made the decision not to see your baby after the birth, and then change 
your mind, you can still ask to see your baby.’  
 
As indicated previously, there was little information to help people understand or navigate the 
health care system. When this type of information was provided, it was limited and only 
identified the different types of health care providers and what type of care they provide. 
Nevertheless, all but one of the documents were organised in a typical care pathway to reflect a 
health care journey, starting with diagnosis, treatments, and follow-up care. The Managing 
Schizophrenia booklet produced by SIGN, also included information before diagnosis and what 
to do when first feeling unwell, and the Brain Injury Rehabilitation in Adults, also from SIGN, 
included information at the end of the document about returning home, and to work or study.  
 
Few patient versions were clearly about empowering readers beyond providing information for 
decision making. There were, however, some notable exceptions. Both patient versions from the 
National Comprehensive Cancer Network (NCCN) included a section describing two roles that 
patients could take in their treatment plan: ‘Some patients want to be involved as little as 
possible. Others want to know everything and share decision making with their doctors.’ The 
NICE patient versions conveyed that the patient has power over their care using statements such 
as, ‘You should have the opportunity to ask any questions you have…’ and ‘If you think that 
your treatment or care does not match this advice, talk to your healthcare team.’ Other patient 
versions provided information for self-care, recognising symptoms and knowing what to do, and 
tips about what people could do at home to manage their own care. The patient versions for Fibre 
and Diabetes, from the Canadian Diabetes Association, and Gastroesophageal Reflux Disease 
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(GERD), from the University of Michigan Hospital and Health Centers, provided practical 
guidance about what foods to eat to increase fibre in the diet while at home, and strategies to 
prevent or reduce reflux. No patient versions, even those that provided self-care strategies, were 
about replacing consultations or counseling. However, while providing information could, in 
fact, be interpreted as a replacement or a second opinion, almost all patient versions included a 
statement advising readers that the information did not replace the advice of health care 
providers. There was also no document that was prescriptive when describing how to take 
medicines; adherence was not an explicit purpose. Instead, reasons for why it was important to 
follow prescribed medications were provided (see the example from the Canadian Diabetes 
Association in Table 4). Other documents encouraged individuals to participate in the health care 
provider consultation by advising readers that decisions should be made along with their doctors. 
Some patient versions explained which type of health care providers would be encountered and 
their role in management (e.g. a radiologist or oncologist). In addition, as indicated earlier, there 
were sections to help people plan for a successful consultation which provided ‘questions to ask 
your doctor.’  
 
Some documents were also written to allay fears and address emotional issues. There was 
acknowledgement of emotional concerns and issues for sensitive topics, such as stillbirth, mental 
health issues and cancer (see Table 4). The patient version about what to expect after a still birth 
from Queensland Health, also provided information about how to deal with and tell family 
members, and the National Comprehensive Care Network, Pancreatic Cancer, included a section 
about emotional challenges and relationships with family and friends. Emotional concerns were 
also covered in other topics which may not be perceived as particularly sensitive. The patient 
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version from the Canadian Diabetes Association about starting insulin included text throughout 
the document recognising that the amount of information could be overwhelming and that 
starting insulin injections may be scary. In contrast to allaying fears, some documents may have 
accomplished the opposite. The patient version for the influenza vaccine from the Centers for 
Disease Control and Prevention provided a proportionately large amount information about 
adverse reactions, how to find help if adverse reactions occur, how to report adverse reactions, 
and how to be compensated for adverse reactions.  
 
[insert table 4] 
 
Personalisation of the information 
Many patient versions (27/34) made attempts to personalise the information. The words ‘you’ or 
‘I’ were often used to personalise within the text and in headings (e.g. ‘What you need to know’ 
or ‘How much fibre do I need?’). Some documents personalised the information by providing 
background information about how the condition might affect feelings, and personal situations in 
life, in particular for sensitive topics such as mental health issues. The SIGN version for 
managing schizophrenia stated: ‘Tiredness and a lack of energy are often described, and may 
mean you are doing a lot less than you used to (sometimes this may be due to the side effects of 
medication).’ Very few provided personal stories (1/34) or scenarios (3/34). One patient version 
featured an introduction from a representative of the NCCN, who wrote about her experience 
with pancreatic cancer and to advocate for more patient information. Five other documents 
provided brief information about how other people felt or managed in similar situations, e.g. 
‘You can resume sexual activities whenever it feels right for you...Some women feel like sex 
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earlier than six weeks but many women want to wait even longer than this.’ When used, 
scenarios were very brief and usually as a section header, for example, ‘I am HIV infected and 
pregnant. When should I start taking anti-HIV medications?’ or ‘I have epilepsy, and my current 
therapy is not helping me. How can I know if [vagus nerve stimulation] is right for me?’ Another 
way to make the information more personally relevant was to include a section at the beginning 
of the document about to whom the information applies (11/34).  
 
Presentation of recommendations and evidence 
We collected data about whether recommendations were recognisable (an important factor in 
professional guidelines) using the four criteria set out by Hussain [11]. It was challenging to 
assess but we found that recommendations were recognisable using at least one of the four 
criteria. All guidelines used common words to communicate the recommendations such as ‘your 
doctor should’, ‘your doctor may offer’ which were easily recognisable. Other times it was 
difficult to determine if the statements were simply about what the treatment will be. For 
example, the guide from ESMO for melanoma listed the tests which would be used and it was 
not clear whether it was based on a recommendation. Specifically, it stated: ‘Sentinel lymph 
node biopsy is a procedure performed for all stage I and stage II patients, except for patients 
whose tumors are 1 mm thick or less.’ In most documents (25/34), recommendations were easily 
recognisable as they were separated out into a paragraph indicating what should be done and for 
whom. An equal number of patient versions did or did not include a heading or title to highlight 
the  recommendations, sometimes this was more clear in some versions (e.g. the heading ‘The 
Task Force Recommendations on Screening for Cervical Cancer: What Do They Mean?’) than in 
others (e.g. the heading ‘Tests you should not be offered’). Only the patient versions from the 
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USPSTF, and one from the AAN, provided recommendations followed by a statement of the 
strength of the recommendation and/or the level of evidence. The USPSTF versions were also 
the only ones to present the system for grading the recommendations and the evidence. As 
indicated above, the evidence on which the recommendations were based was rarely provided as 
quantitative data about effects, and when described in words, interventions were often vaguely 
described as ‘effective’ or ‘helpful’. 
 
Discussion 
This study is the first to analyse patient versions of CPGs currently available. From our 
comprehensive search of institutions with experience producing patient versions, we randomly 
sampled 34 patient versions. We conducted a directed content analysis using themes about 
purpose and content important to patients and the public, and based on this analysis and our 
systematic review of research about patient and public attitudes and beliefs of clinical practice 
guidelines, we have found some gaps in what is provided and what patients and the public 
perceive as helpful, and provide some suggestions for future work (see Table 5).  
 
First, it is questionable whether patients would be able to find these patient versions and then 
identify whether it is credible advice. We found these patient versions primarily through 
professional organisation websites and the versions were called a variety of names. For health 
care professionals, CPG databases and portals overcome this challenge, and perhaps a similar 
website or portal of patient versions by topic may be useful for patients and the public. Our 
review of qualitative research about attitudes and beliefs about guidelines indicated that people 
do not necessarily trust information from guidelines [4]. While the majority of patient versions 
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included logos of national and professional organisations which may convey credible sources, 
logos do not convey that these patient versions are providing recommendations that are based on 
a rigorous process which should be emphasised in these versions.  
 
Second, the review of the literature of patient and public attitudes towards CPGs also revealed 
that patients want background information about their health conditions and about the evidence 
used to make the recommendations [4]. Background information was adequately provided in the 
patient versions, but there was less specific evidence about benefits and harms and instead they 
were advised to speak to their doctors for that information. This seems contrary to the model of 
empowering an individualDirect links to the professional oriented CPGs may be helpful to some 
patients, but  there is a large body of literature around the need to tailor the presentation of 
evidence to patients and the public to make it more user friendly, and therefore guideline 
producers may need to consider how to present evidence for benefits and harms in patient 
versions.   
 
Third, the main purpose of all of the patient versions of guidelines was to provide information or 
direct people to more information. This in itself is a form of empowerment by equipping patients 
with information, but in the patient empowerment discourse used by Dixon-Woods [3], the 
patient versions should provide other information useful to decision making, such as information 
and guidance about values and preferences, feasibility, or costs in some settings. We found that 
less than half of the patient versions included this additional information and few provided self-
care advice, again limiting what people can do for themselves and their sense of control over 
their health care situation. Some patient versions did however provide specific recommendations 
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and information to use in one’s personal life or unique situation, e.g. how to increase fibre in the 
diet. This perhaps could be a goal of patient versions: focus on a recommendation, and then 
provide practical information about how people can achieve it.  
 
Fourth, the need for more personalised information has also been identified by patients and the 
public as important to interpreting health information [4,12]. In this analysis, we saw a variety of 
different methods used to personalise the information. The use of ‘you’ or ‘I’ was used often in 
these versions, but only one version included a personal story. Other documents personalised the 
information in small ways by framing the information under a brief personal scenario. Additional 
exploration of methods to personalise research information has been previously advocated 
through the use of personal stories and decision aids [12]. 
 
These comments are based on the strengths of our analysis, but there are some limitations. 
Although two investigators extracted data and analysed the results, we were not reading the 
patient versions as people directly affected by the topic of the patient version. Instead, the two 
investigators have experience in guideline development (and one has also conducted research to 
communicate evidence to patients and the public), and the team has expertise in both quantitative 
and qualitative research methods.   The data extractors were also both informed by the review of 
the literature of patient and public attitudes towards guidelines and the role of patient materials. 
An inherent limitation of using an informed framework to direct the analysis is the risk of only 
finding text to fit the framework. We however, found text that informed a variety of new 
purposes of the patient versions and little text to address all purposes previously identified. Our 
search was for key institutions that produce patient versions of guidelines, but we did not 
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determine how many institutions produce guidelines and do not produce patient versions. We 
hope that work in future could explore reasons for or against the production of patient versions 
through interviews, focus groups or surveys of guideline producers. We believe our search was 
comprehensive, but we only included English and freely available versions. We searched large 
databases which include national and international clinical practice guidelines, and visited each 
website to search for patient versions.  included patient versions from North America, UK, and 
Australia. It is unclear however, whether the methods to personalise information and the 
different purposes identified from those patient versions might be similar to other countries and 
cultures that may or may not have a longer history of patient communication. We know, in fact, 
that many international organisations have been active in this area, such as the German Agency 
for Quality in Medicine and the Institute for Quality and Efficiency in Health Care, Duodecim in 
Finland, and other institutions of members of the GRADE Working Group. We also know that 
private organisations, such as Kaiser Permanente in the United States, provide patient 
information based on guidelines, but these are not publicly available. We are currently working 
with these groups and others under the umbrella of the GRADE/DECIDE project to contribute to 
this work, and to conduct user-testing into new strategies to communicate CPGs to patients and 
the public and determine if patient versions based on those new strategies meet their needs. 
 
Conclusions 
This study presents the landscape of patient versions of CPGs publicly available to patients and 
the public, which may not be addressing the views of patients and the public. Future work in this 
area could focus on how to provide content which personalises the information, empowers 
people to manage their own care or navigate the health care system, or supports conversations 
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with health care providers. More specifically, research is also needed into how to clearly 
communicate the recommendations, as well as the evidence, patient values and preferences, and 
other feasibility and accessibility issues. Finally, it appears that it would likely be challenging for 
the public and patients to find recommendations and CPGs, and therefore an exploration of how 
they could access the credible wealth of information found in CPGs would be warranted.   
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TABLES 
 
Table 1: List of included key institutions 
1. American Academy of Neurology  
2. American College of Gastroenterology 
3. American College of Physicians 
4. American Society of Clinical Oncology 
5. American Urological Association, Urology Care Foundation 
6. Canadian Diabetes Association 
7. Centers for Disease Control and Prevention 
8. Canadian Paediatric Society 
9. European Society for Medical Oncology 
10. National Comprehensive Cancer Network 
11. NICE 
12. Queensland Clinical Guidelines 
13. Royal College of Obstetricians and Gynaecologists 
14. Scottish Intercollegiate Guidelines Network 
15. University of Michigan Hospital and Health Centers 
16. UpToDate 
17. US Preventive Services Task Force 
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Table 2: General characteristics of 34 patient versions  
Characteristic Number of 
documents 
Main topic area   
Treatment 24  
Diagnosis or screening 7  
Prevention  3  
Type of website   
National agency, professional section 2  
National agency, patient section 10  
Professional organisation, professional section 2  
Professional organisation, patient section 10  
Patient organisation affiliated with professional 
organisation  4  
Patient organisation 0 
Other 6  
Format of document   
Booklet 6 
Webpage 11 
Printed documents  16 
Brochure 1 
Length (pages)  
1 to 3 18 
4 to 9  7 
10 to 20  1 
21 or greater 8 
Number of graphics   
0 13 
1 to 5 13 
6 or greater 8 
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Table 3: Information provided in 34 patient versions 
Type of information provided Number of documents 
(unless otherwise 
indicated) 
Reference to Clinical Practice Guideline   
Citation 13 
Citation and link 14 
No reference 7 
Information about guidelines (%)  
General description of guidelines 11 
Methods to develop the specific 
recommendations 
15 
No information provided 17 
  
Proportion of background information to topic 
area  
16% (IQR 12, 23) 
Proportion of Health care services information 0 (IQR 0, 6) 
  
Information about benefits 27 
Information about harms 19 
  
Information about costs/resources related to 
interventions 
5 
Information about feasibility/accessibility related 
to interventions 
18 
Information about values/preferences related to 
the interventions 
10 
  
Recommendations used words 34 
Recommendations used heading or title 16 
Recommendations in paragraphs 25 
Recommendations had statement of 
evidence/recommendation (level of evidence 2, 
recommendation A). 
4 
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Table 4: Common purposes of patient versions of guidelines and examples  
Purpose Examples 
To empower 
to become 
active 
participants in 
health care 
Don’t feel rushed to leave the hospital. Be sure all your questions are 
answered before you go home…You will develop a plan for follow-up 
care with your health care team before your baby leaves the hospital. 
Canadian Paediatric Society, Bringing baby home from the hospital 
To understand 
and navigate 
the health 
system 
People with breast cancer should talk with their doctors about a follow-up 
care plan and how to coordinate this care between the oncologist and their 
primary care or family doctor…The follow-up care may be provided by 
your oncologist or primary care doctor, as long as your primary care 
doctor has talked with your oncologist about appropriate follow-up care 
and the possible late effects. American Society of Clinical Oncology, What 
to know: ASCO's Guideline on Follow-Up Care for Breast Cancer 
To educate 
and equip with 
information 
For the mother, the risk of infection or a blood clot in the legs or lungs is 
greater with a cesarean delivery than with a vaginal delivery. All women 
who have a cesarean delivery, including women infected with HIV, should 
receive antibiotics to prevent infection. For the infant, the risk of 
temporary breathing difficulties may be greater with a cesarean delivery. 
Centers for Disease Control and Prevention, HIV and Pregnancy 
 
There is also the general risk from overuse of antibiotics leading to strains 
of bacteria becoming resistant…Giving all carriers of GBS antibiotics 
would mean that a very large number of women at very low risk would 
receive treatment they do not need. Royal College of Obstetricians and 
Gynaecologists, Group B Streptococcus infection in newborn babies 
To aid in 
decision 
making  
There’s no single treatment right for everyone. Your healthcare 
professional may use one treatment alone, or several at the same time. 
You and your healthcare professional should talk about what you want 
from treatment and about each treatment choice. American Urological 
Association, Overactive Bladder (OAB) Patient Guide 
To help with 
self-care 
How can I reduce the pain of the tear after birth? 
The following are ways to reduce pain and swelling after having a baby: 
›› Lie down on your back or on your side regularly to help reduce swelling 
in your perineum. Queensland Health, Perineal tears during birth 
To prepare for 
health care 
consultation 
Questions to ask about hyperphosphataemia in chronic kidney disease: 
These questions may help you discuss your condition or the treatments 
you have been offered with your healthcare team. National Institute for 
Health and Care Excellence, Hyperphosphataemia in chronic kidney 
disease 
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Keep a Bladder Diary: Writing down when you make trips to the 
bathroom for a few days can help you and your healthcare professional 
understand your symptoms better. American Urological Association , 
Overactive Bladder (OAB) Patient Guide 
To provide 
resources (e.g. 
more 
information) 
Your health care provider can assist you to do many of these things and 
can direct you to other resources and organizations that will provide 
further assistance and ideas. Queensland Health, What to expect after the 
stillbirth of your baby 
 
Where can I find out more information? 
We hope you have found this booklet helpful. If you need more 
information, we have listed some national organisations that can offer 
information and support.  
Helplines, Breathing Space, 0800 838 587 
Scottish Intercollegiate Guidelines Network, Managing schizophrenia: A 
booklet for patients, carers and their families 
To enhance 
adherence to 
treatments 
Regular checks give you important information about how your glucose 
levels vary during the day, how much insulin you need, and help you 
determine if you’re on track managing your diabetes. Understanding and 
acting on the results of your blood glucose checks is the best way to keep 
your glucose levels in their target range. Canadian Diabetes Association, 
Thinking of starting insulin? 
To allay fears 
or 
acknowledge 
emotions 
Intense reactions are very common. Deep sadness, anxiety, fear, anger, 
guilt, helplessness and despair are just some of the many emotions you 
might experience. 
Grief is a reaction to loss. There is no right or wrong way to grieve. 
Queensland Health, What to expect after the stillbirth of your baby 
 
Feelings of anxiety and depression are common among patients with 
cancer. You may feel anxious before testing and while waiting for the 
results. National Comprehensive Care Network, Pancreatic Cancer 
To enhance 
choice  
They can be taken separately or in combination and your healthcare team 
will take into account which type you prefer, how easy they are to take, 
and other factors when deciding which is the most suitable for you.  NICE, 
Hyperphosphataemia in chronic kidney disease 
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Table 5: Implications 
Accessibility of 
patient versions 
Many patient versions are currently named differently and found on websites 
for health care professionals which may be difficult to find 
 
Web portals geared to patients and the public to access patient versions of 
guidelines may improve accessibility and lend credibility to this information 
Presentation of 
evidence in 
patient versions 
of CPGs  
 
The new format for a summary of evidence developed in this work should be 
used within a patient version of a CPG to communicate the evidence about 
benefits and harms 
 
Future research, such as user testing, should test strategies to disseminate 
evidence along with the quality of the evidence, in particular in people who 
have a special interest in a topic   
Presentation of 
recommendations 
in patient 
versions 
Research into methods currently being used in patient versions to 
disseminate recommendations should be conducted. Interviews or focus 
groups could explore perceptions of recommendations, which can inform 
user testing and randomised controlled trials for effective methods 
 
How to disseminate recommendations, strong or weak recommendations, 
and the additional information in recommendations (including patient values 
and preferences, accessibility and resources) could be explored 
Purpose of 
patient versions 
of CPGs 
Many purposes of patient versions were identified 
 
The development of patient versions to specifically prepare people for 
consultations with their health care providers could be explored 
Personalisation of 
information 
Making information (e.g. research information) more personal and applicable 
to people was identified as important to use and understanding of patient 
versions 
 
Future research should explore effective ways to personalise health 
information, for example through a review of the literature, interviews or 
focus groups with patients and the public, and user testing 
 
